Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p

References

• Lenis A, Lec P, Chamie K, et al. Bladder Cancer: a Review. JAMA. 2020;324(19):1980–1991.
   PubMed Web of Science ®Google Scholar
• Tran L, Xiao JF, Agarwal N, et al. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2020;21:104–121.
   PubMed Web of Science ®Google Scholar
• Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388(10061):2796.
   PubMed Web of Science ®Google Scholar
• Witjes JA, Lebret T, Compérat E, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2016;71:(3)–462–475.
   PubMed Web of Science ®Google Scholar
• Abdollah F, Gandaglia G, Thuret R, et al. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol. 2013;37(3):219–225.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Ven MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted L, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(7):675–691.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32(5):309–316.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Venø M, Damgaard CK, et al. Comparison of circular RNA prediction tools. Nucleic Acids Res. 2016;6:e58–e58.
   Google Scholar
• Zhaoyong L, Chuan H, Chun B, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3): 256–264.
   Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Conn S, Pillman K, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134. 2018.
   PubMed Web of Science ®Google Scholar
• Legnini I, Timoteo GD, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Elsevier Sponsored Documents. 2017;66(1):22–37.e9.
   Google Scholar
• Yang X, Ye T, Liu H, et al. Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer. Mol Cancer. 2021;20(1). DOI:10.1186/s12943-020-01300-8
   Web of Science ®Google Scholar
• Han K, Wang F, Cao C, et al. CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Mol Cancer. 2020;19(1):60. DOI:10.1186/s12943-020-01184-8
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Hammouz R, Kołat D, Kałuzińska Ż, et al. MicroRNAs: their role in metastasis, angiogenesis, and the potential for biomarker utility in bladder carcinomas. Cancers (Basel). 2021;13(4):891.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Wang D, et al. TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer. J Gene Med. 2020;22(2):e3152.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhang X, Li P, et al. MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK. Onco Targets Ther. 2016;9:5091–5099.
   PubMed Web of Science ®Google Scholar
• Xiang J, Wu Y, Li DS, et al. miR-584 suppresses invasion and cell migration of thyroid carcinoma by regulating the target oncogene ROCK1. Oncol Res Treat. 2015;38(9):436–440.
   PubMed Web of Science ®Google Scholar
• Lee SB, Park YS, Sung JS, et al. Tumor suppressor miR-584-5p inhibits migration and invasion in smoking related non-small cell lung cancer cells by targeting YKT6. Cancers (Basel). 2021;13(5):1159.
   PubMed Web of Science ®Google Scholar
• Ueno K, Hirata H, Shahryari V, et al. Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer. 2011;104(2):308–315.
   PubMed Web of Science ®Google Scholar
• Panciera T, Azzolin L, Cordenonsi M, et al. Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol. 2017;18(12):758–770.
   PubMed Web of Science ®Google Scholar
• Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73–79.
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Mousavibahar SH, Hashemnia M, et al. Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection. Ann N Y Acad Sci. 2020;1473(1):48–61.
   PubMed Web of Science ®Google Scholar
• Miranda A, Blanco-Prieto M, Sousa J, et al. Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches. Int J Pharm. 2017;531(1):372–388.
   PubMed Web of Science ®Google Scholar
• Gao W, Jin Y, Hao J, et al. Hydroxyurea affects in vitro porcine oocyte maturation through increased apoptosis and oxidative stress. Biosci Rep. 2021;41(4). DOI:10.1042/bsr20203091
   Google Scholar
• Serna-Salas S, Arroyave-Ospina J, Zhang M, et al. α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence. Mech Ageing Dev. 2021;201:111617.
   PubMed Web of Science ®Google Scholar
• Guan B, Li G, Wan B, et al. RNA -binding protein RBM38 inhibits colorectal cancer progression by partly and competitively binding to PTEN 3’ UTR with miR-92a-3p. Environ Toxicol. 2021;36(12):2436–2447.
   PubMed Web of Science ®Google Scholar
• Luo L, Miao P, Ming Y, et al. Circ-ZFR promotes progression of bladder cancer by upregulating WNT5A via sponging miR-545 and miR-1270. Front Oncol. 2021;10(3310). DOI:10.3389/fonc.2020.596623
   Google Scholar
• Tang W, Zhang L, Li Z. Long noncoding RNA LOC100911498 is a novel regulator of neuropathic pain in rats. Brain Behav. 2021;11(8):e01966.
   PubMed Web of Science ®Google Scholar
• Ma H, Jiang T, Tang W, et al. Transplantation of platelet-derived mitochondria alleviates cognitive impairment and mitochondrial dysfunction in db/db mice. Clin sci. 2020;134(16):2161–2175.
   Web of Science ®Google Scholar
• Velmahos C, Badgeley M, Lo Y. Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images. Cancer Med. 2021;10(14):4805–4813.
   PubMed Web of Science ®Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–310.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K. Circular RNAs are abundant, conserved, and associated with ALU repeats (2013). Rna. 2013;19(2):141–157.
   PubMed Web of Science ®Google Scholar
• Wu S, Yang J, Xu H, et al. Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis. Cell Biol Toxicol. 2021. DOI:10.1007/s10565-021-09591-3
   Web of Science ®Google Scholar
• Li A, Wang WC, Mcalister V, et al. Circular RNA in colorectal cancer. J Cell Mol Med. 2021;25(8):3667–3679.
   Web of Science ®Google Scholar
• Cao W, Zhao Y, Wang L, et al. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression. Cancer Biomarkers. 2019;25(1):101–113.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang H, Li C, et al. CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p. Cancer Cell Int. 2020;20(1):556.
   PubMed Web of Science ®Google Scholar
• Turai P, Nyírő G, Butz H, et al. MicroRNAs, long non-coding RNAs, and circular RNAs: potential biomarkers and therapeutic targets in Pheochromocytoma/Paraganglioma. Cancers (Basel). 2021;13(7):1522.
   PubMed Web of Science ®Google Scholar
• Lin Y, Chen T, Huang Y, et al. Involvement of microRNA in solid cancer: role and regulatory mechanisms. Biomedicines. 2021;9(4):343.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Liu J, et al. Long noncoding RNA GAS5 targeting miR-221-3p/cyclin-dependent kinase inhibitor 2B axis regulates follicular thyroid carcinoma cell cycle and proliferation. Pathobiol J Immunopathol Mol Cell Biol. 2021;1–12. DOI:10.1159/000513338.
   Google Scholar
• Li Q, Li Z, Wei S, et al. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer. J Exp Clin Cancer Res. 2017;36(1):59.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Y, Liu W, et al. Long noncoding RNA KCNMB2-AS1 promotes SMAD5 by targeting miR-3194-3p to induce bladder cancer progression. Front Oncol. 2021;11:649778.
   PubMed Web of Science ®Google Scholar
• Monoe Y, Jingushi K, Kawase A, et al. Pharmacological inhibition of miR-130 family suppresses bladder tumor growth by targeting various oncogenic pathways via PTPN1. Int J Mol Sci. 2021;22(9):4751.
   PubMed Web of Science ®Google Scholar
• Lin J, Tsai K. Circulating miRNAs act as diagnostic biomarkers for bladder cancer in urine. Int J Mol Sci. 2021;22(8). DOI:10.3390/ijms22084278
   Web of Science ®Google Scholar
• Wang H, Niu X, Jiang H, et al. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Aging (Albany NY). 2020;12(16):16021–16034.
   PubMedGoogle Scholar
• Yang X, Wang P. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically. Pathol Res Pract. 2019;215(11):152598.
   PubMed Web of Science ®Google Scholar
• Zhang J, Deng X. Effects of miR-599 targeting YAP1 on proliferation, invasion and apoptosis of bladder urothelial carcinoma cells. Exp Mol Pathol. 2021;118:104599.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu H, Chen H, et al. Glucose promotes epithelial-mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ. J Cell Mol Med. 2020;24(18):10391–10401.
   PubMed Web of Science ®Google Scholar
• Liu J, Li Y, Lin H, et al. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer. 2013;13(1):349.
   PubMed Web of Science ®Google Scholar
• Jiang L, Zuo Z, Lin J, et al. Orthodenticle homeobox OTX1 is a potential prognostic biomarker for bladder cancer. Bioengineered. 2021;12(1):6559–6571.
   PubMed Web of Science ®Google Scholar
• Huang R, Zheng Z, Xian S, et al. Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer. Bioengineered. 2021;12(1):5289–5304.
   PubMed Web of Science ®Google Scholar
• Yang J, Fan L, Liao X, et al. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway. Bioengineered. 2021;12(2):9377–9389.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang D, Shu T, et al. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway. Bioengineered. 2021;12(2):11410–11422.
   PubMed Web of Science ®Google Scholar